Tianjin Medical University General Hospital
Clinical trials sponsored by Tianjin Medical University General Hospital, explained in plain language.
-
Could a single drug halt devastating nerve attacks in NMOSD patients?
Disease control Recruiting nowThis study tests whether eculizumab can quickly reduce disability during an acute attack of neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease that damages the optic nerve and spinal cord. About 110 adults who test positive for a specific antibody (AQP4-IgG…
Phase: PHASE2 • Sponsor: Tianjin Medical University General Hospital • Aim: Disease control
Last updated May 26, 2026 09:06 UTC
-
Zipper therapy breakthrough: new combo may boost recovery in rare brain disease
Disease control Recruiting nowThis study tests a new treatment called 'Modified Zipper Therapy' for people with a rare autoimmune disease called NMOSD. The therapy combines standard treatments with a drug that blocks part of the immune system to help patients recover better from sudden attacks. About 198 adul…
Phase: PHASE3 • Sponsor: Tianjin Medical University General Hospital • Aim: Disease control
Last updated May 26, 2026 08:59 UTC
-
Massive genetic diabetes study launches in china
Knowledge-focused Recruiting nowThis study is creating a large digital registry for people with monogenic diabetes (a rare form caused by a single gene). Researchers will use a mobile app and website to enroll up to 5,000 participants and perform genetic testing. The goal is to map the genetic causes of this di…
Sponsor: Tianjin Medical University General Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 08:57 UTC